Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fulvio Barbaro

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Immunology|October 5, 2020
Microtopography of Immune Cells in Osteoporosis and Bone Lesions by Endocrine DisruptorsRoberto Toni, Giusy Di Conza, Fulvio Barbaro, et al.
Aging|April 27, 2022
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic propertiesJames A McCubrey, Akshaya K Meher, Shaw M Akula, et al.
Journal of Materials Science. Materials in Medicine|July 6, 2014
Growth on poly(L-lactic acid) porous scaffold preserves CD73 and CD90 immunophenotype markers of rat bone marrow mesenchymal stromal cellsAlessandra Zamparelli, Nicoletta Zini, Luca Cattini, et al.
International Journal of Molecular Sciences|May 28, 2020
SCREENED: A Multistage Model of Thyroid Gland Function for Screening Endocrine-Disrupting Chemicals in a Biologically Sex-Specific MannerLorenzo Moroni, Fulvio Barbaro, Florian Caiment, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Immunology|October 5, 2020
Microtopography of Immune Cells in Osteoporosis and Bone Lesions by Endocrine DisruptorsRoberto Toni, Giusy Di Conza, Fulvio Barbaro, et al.
Aging|April 27, 2022
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic propertiesJames A McCubrey, Akshaya K Meher, Shaw M Akula, et al.
Journal of Materials Science. Materials in Medicine|July 6, 2014
Growth on poly(L-lactic acid) porous scaffold preserves CD73 and CD90 immunophenotype markers of rat bone marrow mesenchymal stromal cellsAlessandra Zamparelli, Nicoletta Zini, Luca Cattini, et al.
International Journal of Molecular Sciences|May 28, 2020
SCREENED: A Multistage Model of Thyroid Gland Function for Screening Endocrine-Disrupting Chemicals in a Biologically Sex-Specific MannerLorenzo Moroni, Fulvio Barbaro, Florian Caiment, et al.
Pageof 2